Yogi government is organizing Pharma Conclave 1.0 in Lucknow on 3 February. Leading pharma companies of the country and the world will be included in this. The objective is to make Uttar Pradesh a pharma and medical device manufacturing hub.
Lucknow. Under the leadership of Chief Minister Yogi Adityanath, Uttar Pradesh is now rapidly moving towards becoming the pharmaceutical and medical device manufacturing hub of the country. In this sequence, Yogi government is going to organize “Pharma Conclave 1.0: Investment Opportunities in Uttar Pradesh” on February 3 at Hotel Taj in the capital Lucknow. This conclave will be organized under the joint aegis of Uttar Pradesh Food Safety and Drug Administration (FSDA) and Invest UP.
Inauguration and Chief Guest of Pharma Conclave 1.0
The Pharma Conclave will be inaugurated by Chief Minister Yogi Adityanath. Union Minister for Health, Family Welfare and Chemicals-Fertilizers Jagat Prakash Nadda will address the program through video message. On this occasion, there will be special presence of Deputy Chief Minister Brajesh Pathak, Cabinet Ministers Nand Gopal Gupta Nandi and Rakesh Sachan, Ministers of State Mayankeshwar Sharan Singh and Jaswant Singh Saini and Minister of State (Independent Charge) Daya Shankar Mishra Dayalu.
Participation of leading pharma companies of the country and the world
FSDA Secretary and Commissioner Dr. Roshan Jacob said that Chief Minister Yogi Adityanath has set the target of making Uttar Pradesh a 1 trillion dollar economy, in which the pharma and medical device sector is being given an important role. Many leading pharma companies from India and abroad will participate in Pharma Conclave 1.0.
These include Ramki Group Chairman and Rajya Sabha member Ayodhya Rami Reddy, Sun Pharma Chairman Dilip Shanghvi, Mankind Pharma Chairman Ramesh Juneja, Dr. Reddy’s Chairman Dr. Satish Reddy, Zydus Life Sciences Chairman Pankaj R. Patel and Jinal Mehta, vice chairman of Torrent Pharma. Apart from this, MSN Reddy of MSN Laboratories, Aditya Varman, Director of Dabur and Sandeep Singh, Director of Alchem will also participate in the sessions.
There will be discussion on investment, production and innovation
During the conclave, these industry leaders will discuss in detail the possibilities of investment, production, research and innovation in Uttar Pradesh. The event is being organized in collaboration with leading organizations such as Indian Pharmaceutical Alliance (IPA), Indian Drug Manufacturers Association (IDMA), Bulk Drug Manufacturers Association of India (BDMAI), Organization of Pharmaceutical Producers of India (OPPI) and Federation of Pharma Entrepreneurs (FOPE).
Yogi government’s policies provide strong incentives to investors
Dr. Roshan Jacob said that UP Pharmaceutical and Medical Device Industry Policy 2023 has been implemented to develop the state as a pharma hub. Under this, investors are being given capital subsidy up to 15 percent, 100 percent exemption in stamp duty and complete exemption in electricity duty. Along with this, schemes like UP FDI/FCI and Fortune Global 500 Investment Promotion Policy 2023, Industrial Investment and Employment Promotion Policy 2022 and Global Capability Centers Policy 2024 are making investment easier.
Bulk Drug Park and Medical Device Park are gaining momentum
The effect of these policies is clearly visible. The proposed Bulk Drug Park in Lalitpur and Medical Device Park in Greater Noida are developing rapidly. 81 medical colleges, more than 450 pharma colleges and reputed institutes like NIPER Rae Bareli, KGMU, SGPGI, IIT Kanpur and IIT BHU are providing skilled human resources in the state.
UP’s strong identity in ease of doing business
Uttar Pradesh has made significant improvement in Ease of Doing Business. With a single window system like Nivesh Mitra, the process from application to project operation has been simplified. FSDA is providing timely approvals and regulatory support to investors. Along with this, the state also has a large stock of ready-to-move industrial land available.